| 000 | 01869 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517062720.0 | ||
| 264 | 0 | _c20160621 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0140930 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFung, Monica | |
| 245 | 0 | 0 |
_aMeta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia. _h[electronic resource] |
| 260 |
_bPloS one _c2015 |
||
| 300 |
_ae0140930 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChemotherapy-Induced Febrile Neutropenia _xcomplications |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDecision Trees |
| 650 | 0 | 4 |
_aDiagnostic Tests, Routine _xeconomics |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 | _aEpidemiologic Studies |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 |
_aGalactose _xanalogs & derivatives |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aLung Diseases, Fungal _xdiagnosis |
| 650 | 0 | 4 |
_aMannans _xblood |
| 650 | 0 | 4 |
_aMycoses _xdiagnosis |
| 650 | 0 | 4 |
_aOpportunistic Infections _xdiagnosis |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aKim, Jane | |
| 700 | 1 | _aMarty, Francisco M | |
| 700 | 1 | _aSchwarzinger, Michaël | |
| 700 | 1 | _aKoo, Sophia | |
| 773 | 0 |
_tPloS one _gvol. 10 _gno. 11 _gp. e0140930 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0140930 _zAvailable from publisher's website |
| 999 |
_c25436302 _d25436302 |
||